 trend surviv danish aid patient length surviv relat year diagnosi aids-ind diseas age risk behaviour zidovudin therapi cell count serum immunoglobulin Ig level time diagnosi group consecut adult danish aid patient januari cumul surviv rate confid interv year year year length surviv time patient pneumocysti carinii pneumonia pcp year wherea stabl patient aids-ind diseas surviv similar patient kaposi sarcoma pcp independ predictor shorten surviv cell count /l serum iga level g/l initi diagnosi opportunist infect pcp addit multivari analysi improv surviv recent year patient pcp independ factor length surviv aid patient variabl determin progress cell count serum iga level diseas surviv patient pcp median surviv month